$1.24 Billion is the total value of Davide Leone & Partners Investment Co Ltd.'s 15 reported holdings in Q2 2019. The portfolio turnover from Q1 2019 to Q2 2019 was - .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
BABA | New | ALIBABA GROUP HLDG LTDput | $249,532,000 | – | 1,472,600 | +100.0% | 20.10% | – |
APC | New | ANADARKO PETE CORP | $112,951,000 | – | 1,600,773 | +100.0% | 9.10% | – |
ARRY | New | ARRAY BIOPHARMA INC | $84,196,000 | – | 1,817,309 | +100.0% | 6.78% | – |
LGFA | New | LIONS GATE ENTMNT CORPcl a vtg | $13,587,000 | – | 1,109,178 | +100.0% | 1.10% | – |
LGFB | New | LIONS GATE ENTMNT CORPcl b non vtg | $1,817,000 | – | 156,483 | +100.0% | 0.15% | – |
RHT | New | RED HAT INC | $1,239,000 | – | 6,601 | +100.0% | 0.10% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-08-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
BERKSHIRE HATHAWAY INC DEL | 19 | Q3 2023 | 7.8% |
ACADIA HEALTHCARE COMPANY IN | 9 | Q4 2021 | 14.1% |
BLACKBERRY LTD | 9 | Q4 2021 | 10.1% |
ILLUMINA INC | 8 | Q4 2020 | 8.8% |
ENCOMPASS HEALTH CORP | 7 | Q2 2022 | 98.2% |
INCYTE CORP | 6 | Q1 2021 | 5.0% |
AMERICAN WELL CORP | 6 | Q4 2021 | 2.7% |
BIOMARIN PHARMACEUTICAL INC | 5 | Q3 2021 | 9.1% |
VONTIER CORPORATION | 5 | Q4 2021 | 9.9% |
QIAGEN NV | 5 | Q1 2021 | 7.7% |
View Davide Leone & Partners Investment Co Ltd.'s complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-15 |
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-15 |
13F-HR | 2022-05-16 |
13F-HR | 2022-02-14 |
View Davide Leone & Partners Investment Co Ltd.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.